References
- Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980;287:795–801.
- Wetmore C. Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models. Curr Opin Genet Dev 2003;13:34–42.
- Hammerschmidt M, Brook A, McMahon AP. The world according to hedgehog. Trends Genet 1997;13:14–21.
- Wicking C, Smyth I, Bale A. The hedgehog signaling pathway in tumorigenesis and development. Oncogene 1999;18:7844–7851.
- Matisse MP, Joyner AL. Gli genes in development and cancer. Oncogene 1999;18:7852–7859.
- Taylor MD, Liu L, Raffel C, . Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002;31:306–310.
- Xie J, Murone M, Luoh SM, . Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998;391:90–92.
- Berman DM, Karhadkar SS, Maitra A, . Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003;425:846–851.
- Thayer SP, di Magliano MP, Heiser PW, . Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851–856.
- Watkins DN, Berman DM, Burkholder SG, . Hedgehog signaling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003;422:313–317.
- Karhadkar SS, Bova GS, Abdallah N, . Hedgehog signaling in prostate regeneration, neoplasia and metastasis. Nature 2004;431: 707–712.
- Yoshizaki A, Nakayama T, Naito S, . Expressions of Sonic hedgehog, patched, smoothened and Gli-a in human intestinal stromal tumors and their correlation with prognosis. World J Gastroenterol 2006;12:5687–5691.
- Bhardwaj G, Murdoch B, Wu D, . Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001;2:172–180.
- Hofmann I, Stover EH, Cullen DE, . Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 2009;4:559–567.
- Gao J, Graves S, Koch U, . Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell 2009;4:548–558.
- Outram SV, Varas A, Pepicelli CV, . Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. Immunity 2000;13:187–197.
- Gutierrez-Frias C, Sacedon R, Hernández-López C, . Sonic hedgehog regulates early human thymocyte differentiation by counteracting the IL-7-induced development of CD34 + precursor cells. J Immunol 2004;173:5046–5053.
- Schmitt TM, Zuniga-Pflucker JC. Thymus-derived signals regulate early T-cell development. Crit Rev Immunol 2005;25:141–159.
- Detmer K, Walker AN, Jenkins TM, . Erythroid differentiation in vitro is blocked by cyclopamine, an inhibitor of hedgehog signaling. Blood Cells Mol Dis 2000;26:360–372.
- Stewart GA, Lowrey JA, Wakelin SJ, . Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4 + T cells. J Immunol 2002;169:5451–5457.
- Lowrey JA, Stewart GA, Lindey S, . Sonic hedgehog promotes cell cycle progression in activated peripheral CD4 + T lymphocytes. J Immunol 2002;169:1869–1875.
- Bai LY, Chiu CF, Lin CW, . Differential expression of sonic hedgehog and Gli1 in hematological malignancies. Leukemia 2008;22:226–228.
- Dierks C, Beigi R, Guo GR, . Expansion of bcr-abl-positive leukemic stem cells is dependent on hedgehog pathway activation. Cancer Cell 2008;14:238–249.
- Zhao C, Chen A, Jamieson CH, . Hedgehog signaling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009;458:776–780.
- Dierks C, Grbic J, Zirlik K, . Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 2007;13:944–951.
- Hegde GV, Peterson KJ, Emanuel K, . Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol Cancer Res 2008;6:1928–1936.
- Sengupta A, Banerjee D, Chandra S, . Deregulation and cross talk among sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007;21:949–955.
- Kobune M, Takimoto R, Murase K, . Drug resistance is dramatically restored by hedgehog inhibitors in CD34 + leukemic cells. Cancer Sci 2009;100:948–955.
- Nguyen HQ, Hoffman-Liebermann B, Liebermann DA. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell 1993;72: 197–209.
- Krishnaraju K, Hoffman B, Liebermann DA. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells. Blood 1998;92:1957–1966.
- Riobó NA, Lu K, Ai X, . Phosphoinositide 3-kinase and Akt are essential for sonic hedgehog signaling. Proc Natl Acad Sci USA 2006;103:4505–4510.
- Elia D, Madhala D, Ardon E, . Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 2007;1773:1438–1446.
- Berasi SP, Huard C, Li D, . Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase. J Biol Chem 2006;281:27167–27177.
- Spira AI, Carducci MA. Differentiation therapy. Curr Opin Pharmacol 2003;3:338–343.
- Massard C, Deutsch E, Soria JC. Tumor stem cell-targeted treatment: elimination or differentiation. Ann Oncol 2006;17:1620–1624.
- Nowak D, Stewart D, Koeffler HP. Differentiation therapy of leukemia: 3 decades of development. Blood 2009;113:3655–3665.
- Zhang TD, Chen GQ, Wang ZG, . Arsenic trioxide, a therapeutic agent for APL. Oncogene 2001;20:7146–7153.
- Douer D, Tallman MS. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 2005;23:2396–2410.
- Emadi A, Gore SD. Arsenic trioxide - an old drug rediscovered. Blood Rev 2010;24:191–199.
- Beauchamp EM, Ringer L, Bulut G, . Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J Clin Invest 2011;121:148–160.
- Kim J, Lee JJ, Kim J, . Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc Natl Acad Sci USA 2010;107: 13432–13437.